Philip Low, Ph.D., who directs the Purdue Center for Drug Discovery, spoke about ligand-targeted therapeutic and imaging agents for multiple diseases at his recent Flexner Discovery Lecture.
For a complete schedule of the Flexner Discovery Lecture series and archived video of previous lectures, go to www.mc.vanderbilt.edu/discoveryseries.
